Background: Tetanus vaccinations for wound prophylaxis are routinely administered in emergency departments (ED). Current recommendations from the Centers for Disease Control and Prevention (CDC) and Advisory Committee on Immunization Practices (ACIP) regarding tetanus administration for wound prophylaxis differentiate between the tetanus and diphtheria (Td) and the tetanus, diphtheria, acellular pertussis (Tdap) formulations and when they should be administered. Lack of knowledge regarding these recommendations, different formulations, and techniques to locate patient immunization history can lend to increased duplicate and inappropriate vaccinations. Objective: The purpose of this prospective, interventional study with a historical control was to evaluate the impact of a pharmacy-driven education series on the proportion of duplicate and inappropriate tetanus vaccinations administered in a level I trauma center ED. Methods: Three months of tetanus vaccinations administered in the ED after this education were analyzed and compared with a historical control. The primary outcome is the percentage of vaccinations considered duplicates (previous vaccination within the past 5 years) when patients' medical record was reviewed for immunization history. Secondary end points include the percentage of vaccinations considered nonadherent (according to current CDC-ACIP guidelines), the total cost of all duplicate vaccinations, and the percentage of vaccination orders that had the wrong formulation administered. Results: The percentage of duplicate vaccinations decreased from 9.9% (25 vaccinations) to 5.5% (14 vaccinations) (P = .067) from the preintervention group to the postintervention group. Nonadherent vaccinations compiled 3.6% versus 2.8% of the vaccinations (P = .611) and incorrect formulations given were 18.2% versus 11.4% (P = .176) in the preintervention and postintervention groups, respectively. Conclusion: The study suggests that multiple formulations of tetanus vaccinations and fragmented documentation of immunizations increase the prevalence of medication errors related to tetanus vaccinations. It also indicates that interventions more enduring than education are required to prevent these errors.
Introduction
Incidence of tetanus in the United States has been declining at a constant rate since the beginning of case documentation in 1940; however, there were still a reported 233 cases of tetanus between 2001 and March 2008, with an average of 29 cases per year. 1 Tetanus vaccination was reported for only 39.5% of these patients. Postexposure prophylaxis of tetanus upon presentation in an emergency department (ED) for wounds could have possibly prevented these cases.
Emergency department providers have varying knowledge regarding the most current tetanus immunization guidelines as well as the differences between available vaccination products. The Centers for Disease Control and Prevention (CDC) and Advisory Committee on Immunization Practices (ACIP) currently recommend routine booster vaccination with tetanus and diphtheria (Td) every 10 years for immunity against tetanus. 2 However, if a patient obtains a wound that is anything beyond "minor and uncontaminated," they should receive another Td if it has been ≥5 years since their last vaccination.
Pertussis outbreaks in the 2000s prompted the CDC to recommend a single dose of tetanus, diphtheria, acellular pertussis (Tdap) for adult patients in an attempt to increase population immunity. 4 This single dose of Tdap should replace one of the previous recommended Td vaccinations, either a routine booster or a Td associated with wound care. 5 The committee has not recommended multiple administrations of Tdap in any instance except in pregnancy. 6 However, the current trend of pertussis outbreaks in the United States is still frightening. There were over 28 000 pertussis cases reported to the CDC in 2014, an increase of 18% from the previous year. 7 Immunizing the public majority with Tdap could provide a nationwide effect for the benefit of at-risk infants.
Determining which patients require vaccination can be difficult as this information is often based on available records within an institution or by patients' report. Not only may records be lacking, but patients may also be unresponsive or altered following injury. A study by Stubbe et al showed the inaccuracies of verbal immunization history collection compared with use of a rapid immunoassay for tetanus immunity of patients presenting with wounds in an ED. 8 No studies have yet documented a cost burden for duplicate vaccine administrations to an individual hospital.
Proper history collection, utilization of electronic health records, and appropriate assessment of wounds has the potential to decrease unnecessary vaccination of patients. Education regarding the current guidelines, tetanus formulations, and techniques to extract patient immunization records may have the potential to prevent duplicate vaccinations and uncover nonadherence to guidelines.
Methods

Study Design
This prospective, interventional study with a historic control was performed in the ED of an academic tertiary care medical center with level I trauma status. Educational interventions were provided during fall 2015 by an emergency medicine (EM) pharmacist. A presentation at the weekly EM conference was provided to the Department of Emergency Medicine providers. This presentation detailed key components from the CDC-ACIP Guidelines, the type of formulations available, and locations in the electronic medical record (EMR) that patient immunization history can be located. Approximately 75% of the current EM medicine residents and between 3 to 5 attending physicians attend conference on any given week. A similar presentation was presented and also dispersed electronically to the entire pharmacy department and the EM medical residents and faculty. Finally, an announcement was made at ED nursing shift changes (2 morning shifts and 2 evening shifts) which explained the important of selecting the correct formulation. Along with these educational interventions, signs depicting the 2 formulations were affixed to all medication dispensing machines containing tetanus vaccinations. Three months of tetanus vaccinations administered in the ED after this education were analyzed and compared with a historical control, prior to the education.
Study Population
Patients could be included if they were ≥18 years of age and had an electronic order for a tetanus vaccination (either Tdap or Td) that was administered in the ED. Patients were excluded if they never received their ordered vaccination or if they were emergently registered under a pseudonym. Pregnant patients were also excluded. If a patient received duplicate vaccinations within the same time period of study, the most recent vaccination and encounter were used as the primary vaccination order.
Data Collection
Demographics, including age, gender, race, and ethnicity, were collected from the patient EMR. The primary vaccination order included in either preintervention time frame of December 1, 2013, through February 28, 2014, or postintervention time frame of December 1, 2015, through February 29, 2016, had the following information collected: formulation ordered, formulation administered, date and time of administration, ordering provider including EM residents, attendings, physician assistants or nurse practioners (PA/NP), and off-service residents, and the reason for administration (as obtained by the EMR). This order was compared with patient's immunization history and classified as either "duplicate" or "nonadherent." Vaccinations were considered duplicate if the patient had a tetanus vaccination administered within the previous 5 years of the current order. Vaccinations were considered nonadherent if they were not following the current CDC-ACIP guidelines. Therefore, if a patient was ordered a Tdap when they had already received a Tdap in their adult lifetime or if the patient was ordered a Td when they had not yet received a Tdap, the current vaccination was considered nonadherent. If a patient had multiple tetanus vaccinations ordered and given within the same 3-month time period, the most recent vaccination was used to compare with the others (considered past immunizations) and other encounters were excluded. If a patient had previous vaccinations documented within the EMR, formulation type and date of administration were recorded. Data regarding which formulation was retrieved for each vaccination order was collected from reports of the automated medication dispensing system (AMDS) machines. Reports indicate which formulation the nurse selected from the list, but not necessarily which formulation was removed from the machine, as both Tdap and Td were stored in the fridge, without requiring a scan for removal.
End Points
The primary end point was the percentage of vaccinations considered duplicates in each time period. Secondary end points included the percentage of vaccinations considered nonadherent in each time period, the total cost of all duplicate vaccinations in each time period, and the percentage of orders that had the wrong formulation administered in each time period.
Analysis
A power analysis was done to determine the required number of tetanus vaccination orders to collect. Using a 25% decrease as a clinically significant for the primary outcome, 506 tetanus vaccinations are required (P = .05, power 80%). A total of 253 tetanus vaccinations were collected from each chart review period (December 1, 2013-February 28, 2014, preeducation, and December 1, 2015-February 29, 2016, posteducation) to complete the 506 required vaccinations. Differences in demographics and the study outcomes were compared between the preeducation and posteducation study periods using chi-square for categorical and t test for continuous variables, respectively. Microsoft Excel 2010 was used to perform all statistical analysis.
Results
Patients
A total of 277 patients were screened for the preintervention period to collect 253 tetanus vaccination orders. Of these patients, 11 were excluded for emergent registration, 1 excluded for pregnancy, 1 patient had multiple tetanus vaccination orders in the same time period and thus duplicate encounters were excluded except for the most recent, and 11 patients had tetanus vaccination orders that were never given. A total of 311 patients were screened for the postintervention period. Of these, 8 were excluded for emergent registration and 50 were excluded as the vaccination was never given (assumed due to lack of administration documentation). See Figure 1 for the exclusion and data collection distribution. Patients were generally middle-aged, non-Hispanic, white males ( Table 1 ). The majority of tetanus vaccination orders was Tdap formulation (97.6% preintervention, 98.8% postintervention) and ordered by advanced practice providers (including physician assistants and nurse practitioners) and EM medical residents. See Table 2 for more information about the tetanus vaccination orders. Indications for vaccination were mostly a nonspecific injury, followed by falls and assaults. There were no significant differences between the 2 groups regarding these characteristics.
Primary and Secondary End Points
The percentage of duplicate vaccinations, the primary outcome, decreased from 9.9% (25 vaccinations) to 5.5% (14 vaccinations) (P = .067) from the preintervention to postintervention group. When the total number of duplicate vaccinations was multiplied by the wholesale acquisition cost of $42.94, there was a cost difference of $472.34 between preintervention and postintervention groups. A total of 25 duplicate orders (all Tdap) in preintervention group cost $1073.50 and 14 duplicate orders in the postintervention group cost $601.16. The percentage of vaccinations that were considered nonadherent to CDC-ACIP guidelines was 3.6% in the preintervention group compared with 2.8% in the postintervention group (P = .611). According to reports from the AMDS machines, formulations were pulled which did not match the electronic medication order in 18.2% of the orders in the preintervention group. This decreased to 11.4% in the postintervention group, however, which was also not significant (P = .176).
Discussion
Although incidence of duplicate vaccinations did decrease between the preintervention and postintervention group, it was not statistically significant. One previous study by Talan et al showed that out of approximately 2000 patients presenting to the ED with wounds, 35% of patients did not receive indicated prophylaxis, and 8% received unnecessary prophylaxis, based on wound type and indications. 9 Although our study did not look at instances of missed prophylaxis, our initial unnecessary or duplicate prophylaxis rate was similar to the data collected by Talan and colleagues at 9.9%. Vaccination in a patient who is already appropriately immunized may have the potential for undesirable side effects with repeated administration. A second Tdap administration within 4 to 6 years of initial has been shown to cause an increased prevalence of side effects compared with the first injection. These side effects include injection site (pain, swelling, erythema) as well as systemic (myalgia, headache, fever) effects. 10 A previous study showed that although an overall increase in adverse effects from Tdap administration between previous administration interval <2 years versus >2 years, there was no difference between moderate/severe adverse reactions. 11 Contrarily, another randomized controlled trial (RCT) compared administration of Tdap 1 month after either Td or a placebo injection. Side effects in the multiple vaccination arm were similar to previous studies; however, there was no difference in side effects between the single vaccination and double vaccination groups. 12 We did not monitor for side effects in our study; however, any vaccination has the potential to cause side effects, and thus the effect of duplicate vaccinations is unclear.
A more objective burden of duplicate vaccination is the cost to an institution. Decreasing duplicate vaccination orders provides cost savings to any institution; however, the difference in cost between the Td and Tdap formulations is greater than $15 (according to wholesale acquisition cost) which can become quite significant when selecting products. It has been predicted that replacing Td with Tdap for all indicated wounds would cost an additional $0.01-$0.03 per-member, per-month for health care plans when prevented pertussis cases are factored in. 13 It is out of the scope and feasibility of this study to quantify cost savings based on prevented cases of tetanus and pertussis. Although the decrease seen in duplicate vaccinations was Note. PA = physician assistants ; NP =nurse practioners not significant, any trend toward a reduction in duplicate vaccinations could contribute to an institutional cost savings. It is clear from our study that providers at our institution prefer Tdap to Td. Although not formally surveyed, many providers cite the pertussis protection as their reason for preference; this would include giving Tdap as a booster tetanus vaccination, despite an adult previously receiving their single recommended dose. The guidelines recommending a single adult Tdap dose to replace a Td booster have not been updated (at the time of this writing) in over 5 years. It is not known exactly how long the duration of pertussis immunity is after vaccination. However, recent reports in adolescents and children have suggested that immunity wanes significantly after primary series administration and may only last for 5 years or less. 14, 15 Further research would be beneficial in determining the duration of pertussis immunity in adults and thus clarify the need for more than one pertussis vaccination (Tdap) in a lifetime. This information would help determine which formulation is truly the most appropriate tetanus vaccination to administer in the ED setting.
Education is a difficult intervention to perform in an academic teaching facility. The education provided was not able to show statistical significance in the reduction of duplicate vaccinations, nonadherent vaccinations, and appropriate formulation administration. Not all ED providers or nurses were able to be provided with education despite attempts to capture by providing information at conference and multiple shift changes. Also, many other factors can interfere with continued adherence, including but not limited to time constraints with patient encounters, rotation of new providers, hiring of new nurses and pharmacists, and other unknown circumstances. Finally, education was not provided directly to the advanced practice providers in the ED-who as reported by our data, ordered a large proportion of the tetanus vaccinations. There have been no previous studies that have documented the impact of pharmacy-driven interventions on tetanus vaccinations. Physician notifications regarding tetanus booster evaluation in primary care settings have been shown to be beneficial; however, as not all wounds require tetanus vaccinations, it is unlikely that interventions similar to this will be advantageous in an ED setting. 17 Another study ascertained the cost benefit of testing wounded ED patients for tetanus immunity prior to administration of any tetanus prophylaxis. 17 An intervention such as this would remove the need to locate patient immunization history or make prophylaxis decisions based on patient recall; however, instituting a blood test (albeit finger-prick) with every patient presentation involves cost and time commitments. Electronic notifications, linking immunization history with vaccination orders, and requiring scanning of products upon removal from medication dispensing machines are hard-stop interventions that could be implemented to decrease duplicate vaccinations and inappropriate formulation administration, respectively. These interventions are enduring despite changes in staff and practices and likely offer more benefit than education.
Strengths and Limitations
This study is limited by the short duration of data collection and the retrospective nature of chart review and historical controls. There is also great heterogeneity between the providers who ordered the vaccinations, the pharmacists who verified these orders, and the nurses who retrieved and administered vaccinations. These are a few of the many confounders that may affect the measured impact of pharmacy education on the other health care professionals. Despite these limitations, this is the first study that has evaluated the tetanus vaccination practices of a level I trauma center ED and thus offers some insight on what these practices are and how they may or may not be affected by education.
Conclusions
This study suggests that interventions other than education are required to change common immunization practices in the ED. We were also able to demonstrate the common prevalence of duplicate vaccinations and administration of incorrect formulations. This study provokes medication discussion regarding the safety and necessity of multiple tetanus formulations as well as a noticeable nonadherence to current vaccination guidelines.
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